Aortic-stenosis-treatment-1200x800.png

August 28, 2026 AbhijitUncategorized

When aortic stenosis treatment starts causing breathlessness, chest discomfort, dizziness, or reduced physical activity, choosing the right treatment becomes an important decision. The appropriate aortic stenosis treatment depends on the severity of valve narrowing, symptoms, age, overall health, valve anatomy, and suitability for catheter-based or surgical treatment. This guide explains the main treatment options, including aortic valve replacement and TAVR, to help patients and healthcare readers understand the decision-making process.

What Is Aortic Stenosis?

Aortic stenosis occurs when the aortic valve becomes narrowed and does not open normally. This restricts blood flow from the left ventricle into the aorta, making the heart work harder to pump blood throughout the body.

Aortic stenosis may develop because of age-related valve calcification, a bicuspid aortic valve, or congenital abnormalities. Some patients remain stable for years, while others develop symptoms that require closer evaluation and treatment.

Common symptoms may include:

  • Breathlessness, particularly during exertion
  • Chest pain or pressure
  • Dizziness or fainting
  • Reduced exercise tolerance
  • Fatigue
  • Swelling in the legs in some patients

A patient with severe narrowing and new exertional breathlessness, for example, may require more than routine observation and should undergo specialist assessment.

Aortic Stenosis Treatment: When Is Treatment Needed?

Aortic Stenosis treatment hyderabad

Treatment is determined after evaluating the severity of valve disease and its effect on the heart. Echocardiography is central to this assessment, while additional cardiac imaging may be recommended in selected cases.

For patients with mild or moderate disease and no significant symptoms, regular monitoring may be appropriate. Severe symptomatic aortic stenosis generally requires evaluation for valve replacement.

 

The treatment decision considers:

  • Severity of valve narrowing
  • Presence and progression of symptoms
  • Left ventricular function
  • Valve anatomy
  • Age and overall health
  • Previous cardiac procedures
  • Surgical risk
  • Suitability for transcatheter treatment

Aortic stenosis should therefore not be treated using a single approach for every patient.

Aortic Valve Replacement: Surgical or Transcatheter?

When valve replacement is indicated, two major approaches are considered: surgical aortic valve replacement and transcatheter aortic valve replacement.

Open Heart Surgery

Surgical aortic valve replacement involves removing the diseased valve and replacing it with a prosthetic valve through cardiac surgery.

This approach may be appropriate when the patient’s anatomy, age, associated cardiac conditions, or other surgical requirements make surgery preferable. A surgical approach can also allow other cardiac problems to be addressed during the same operation when necessary.

TAVR Procedure

Transcatheter aortic valve replacement (TAVR) is a minimally invasive valve replacement procedure in which a replacement valve is delivered through a catheter, commonly through an artery in the groin.

TAVR can be an important treatment option for appropriately selected patients with severe aortic stenosis. The final decision requires assessment of valve anatomy, vascular access, clinical condition, and the patient’s overall treatment goals.

TAVR vs Open Heart Surgery: How Is the Choice Made?

The question of TAVR vs open heart surgery is highly individual. Neither option should automatically be considered better for every patient.

A heart team may assess:

  • Patient age and life expectancy
  • Surgical risk
  • Aortic valve anatomy
  • Bicuspid or tricuspid valve anatomy
  • Aorta and vascular access
  • Existing coronary artery disease
  • Previous cardiac surgery
  • Potential need for additional cardiac procedures
  • Long-term valve considerations

For example, an elderly patient with severe symptomatic aortic stenosis and suitable anatomy may be considered for TAVR, while another patient may benefit more from surgical replacement because of anatomical or associated cardiac factors.

TAVR Valve Types and Patient Selection

Different transcatheter valves have different designs and deployment characteristics. Valve selection depends on anatomical measurements, the native valve, the aortic root, coronary artery position, vascular access, and other clinical factors.

Who Is Eligible for TAVR?

Eligibility for TAVR cannot be determined by age or symptoms alone. A detailed evaluation is generally required before recommending the procedure.

Assessment may include:

  • Echocardiography
  • CT-based anatomical evaluation
  • Coronary assessment when appropriate
  • Vascular access assessment
  • Clinical and surgical risk evaluation
  • Review by a multidisciplinary heart team

This evaluation helps determine whether TAVR is technically suitable and whether it offers an appropriate treatment pathway for the individual patient.

TAVR Recovery and Possible Complications

One of the reasons TAVR may be considered is that it avoids conventional open-heart surgery in suitable patients. Recovery varies according to age, general health, vascular access, and whether complications occur.

Possible complications can include bleeding or vascular problems, stroke, heart rhythm disturbances requiring a pacemaker, valve-related problems, kidney complications, infection, or other procedure-related events. The individual risk depends on the patient’s clinical and anatomical characteristics.

Patients should discuss expected recovery, medication requirements, follow-up, and warning signs with their treating team before the procedure.

Aortic Stenosis in Bicuspid and Congenital Valves

A bicuspid aortic valve has two leaflets instead of the usual three and can become narrowed over time. Treatment planning can be more complex because valve and aortic anatomy may differ from that seen in typical degenerative aortic stenosis.

Patients with congenital aortic stenosis also require individualized assessment. A bicuspid aortic valve cardiologist or congenital aortic stenosis specialist may be involved depending on the patient’s age, anatomy, associated conditions, and treatment requirements.

 

How Should Patients Choose an Aortic Stenosis Specialist?

Selecting an aortic stenosis doctor involves more than searching for a general cardiology consultation. Patients may benefit from an aortic stenosis specialist experienced in evaluating valve disease and discussing both surgical and catheter-based treatment options.

A specialist assessment can help clarify:

  • Whether the stenosis is mild, moderate, or severe
  • Whether symptoms are related to the valve
  • Whether valve replacement is required
  • Whether TAVR may be suitable
  • Whether surgery should be considered
  • What additional tests are necessary

Patients searching for the best cardiologist for aortic stenosis should focus on appropriate expertise, multidisciplinary evaluation, procedural experience, and an individualized treatment plan rather than relying on a single treatment method.

TAVR Cost in India and Expected Outcomes

The TAVR cost in India can vary depending on the valve selected, hospital, diagnostic investigations, procedural requirements, length of stay, and individual medical needs. Patients should obtain a procedure-specific estimate from the treating hospital rather than relying on a general online figure.

Similarly, TAVR success and outcomes depend on patient selection, anatomy, clinical condition, procedural factors, and follow-up care. TAVR for elderly patients may be considered when the overall clinical assessment supports a transcatheter approach.

Also read: Best Cardiologist for TAVI-TAVR in Hyderabad 

Expert Evaluation Matters

Aortic stenosis can progress from a condition that requires monitoring to one requiring valve replacement. Recognizing symptoms and obtaining timely specialist evaluation can help patients understand when intervention should be considered.

Dr. C. Raghu is a senior interventional cardiologist with experience in structural heart interventions, including TAVR. Patients seeking a personalized assessment can discuss their diagnosis, valve anatomy, available treatment options, and suitability for intervention with his cardiac team.

For detailed information about aortic stenosis treatment and treatment considerations, patients can refer to Dr. C. Raghu’s dedicated clinical resource.

The practical takeaway is simple: the right treatment for aortic stenosis depends on the individual patient. A thorough evaluation can help determine whether monitoring, surgical aortic valve replacement, or TAVR is the most appropriate pathway.

For evaluation and guidance regarding aortic stenosis and valve replacement options, consult Dr. C. Raghu for an individualized cardiac assessment.


tavr-specialist-in-india.webp

April 28, 2026 AbhijitHearty Life

The Heart Valve Condition That Affects Millions — and the Procedure Changing Its Outcome

Severe aortic stenosis is one of the most serious cardiac valve conditions affecting adults in India today, often requiring consultation with a TAVR expert in Hyderabad for advanced and minimally invasive treatment options. The aortic valve — which regulates blood flow from the heart to the rest of the body — progressively narrows over time, forcing the heart to work harder with every beat. Without timely treatment, the condition carries a steep prognosis: within two years of the onset of severe symptoms, more than half of untreated patients do not survive. 

For decades, the only proven treatment was open-heart surgery. For patients who were elderly, frail, or burdened by multiple co-existing illnesses, that surgery was too risky to offer. Families were told there was nothing to be done.

Transcatheter Aortic Valve Replacement—known as TAVR, or equivalently as TAVI (Transcatheter Aortic Valve Implantation)—has fundamentally rewritten that story. Understanding what TAVR is, how it works, and who it helps is now essential knowledge for every patient with aortic stenosis and every family navigating this diagnosis.

What TAVR Actually Involves

In TAVR—a cornerstone of modern TAVR cardiology—a new prosthetic aortic valve is delivered to the heart not through a chest incision, but through a thin, flexible catheter navigated from outside the body. The most common route is through the femoral artery in the groin, a blood vessel large enough to carry the crimped prosthetic valve to the heart under X-ray and ultrasound guidance.

Once the new valve reaches the diseased native valve, it is expanded — either by a small balloon or by a self-expanding mechanism — and takes over the valve’s function immediately. The diseased native valve leaflets are pushed aside; the new valve sits within them and opens and closes with each heartbeat.

No incision is made in the chest. The heart continues beating throughout. Most patients receive sedation rather than full general anesthesia. They are sitting up and taking fluids the same day. Most are discharged within two to four days.

Recovery is measured in weeks, not months. Patients who undergo TAVR at a high-quality center—performed by an experienced TAVR/TAVI specialist in Hyderabad like Dr. Raghu—typically return to normal daily activities within one to three weeks of the procedure.

TAVI and TAVR refer to the same procedure. TAVR (replacement) is the terminology used in North America; TAVI (implantation) is used widely in Europe and Asia. Clinically, there is no difference.

Also read: Top 10 Cardiologists in Hyderabad: How to Choose Best One  

Why TAVR Is Particularly Significant for Indian Patients

India carries one of the world’s largest burdens of valvular heart disease. Rheumatic heart disease — historically underdiagnosed — has left a significant proportion of the older population with damaged valves. The rising prevalence of degenerative age-related aortic stenosis compounds this burden further.

Until TAVR, many of these patients were turned away. Open-heart surgery was unavailable in their region, too expensive, or too risky given their age and health. TAVR changes all three of those barriers simultaneously. It extends the eligible patient population dramatically—elderly patients, frail patients, those with prior cardiac surgery, and those with severe lung or kidney disease—all of whom previously had no safe treatment option.

A qualified TAVR/TAVI doctor in India can now evaluate these patients, most of whom can be treated safely and return to a quality of life that aortic stenosis had progressively stripped away.

The economic dimension matters too. TAVR experts in India is available at costs that are a fraction of equivalent care in the United States, the United Kingdom, or Australia—without any compromise in clinical quality at top Indian centers. This has made India an increasingly significant destination for TAVR medical tourism among overseas Indian patients and international patients seeking expert, affordable structural heart care.

Also read: Myocardial Infarction: Heart Attack Causes, Symptoms & Treatment 

The Heart Team: Why TAVR Outcomes Depend on More Than the Operator

TAVR is not a procedure performed by a single physician in a standard catheterisation laboratory. Best practice TAVR requires what is known as a Heart Team — a multidisciplinary group that evaluates every candidate collectively before any procedure is planned.

The Heart Team includes an interventional cardiologist with specific structural heart disease training, a cardiac surgeon capable of open valve replacement, a cardiac imaging specialist for echocardiography and CT planning, a cardiac anaesthesiologist, and a specialist nursing team. The team reviews each patient’s clinical and anatomical information, discusses treatment options, and arrives at a consensus recommendation.

This multi-specialist framework exists because TAVR decisions are genuinely complex. Anatomy varies between patients in ways that significantly affect both device selection and implantation strategy. Surgical risk scores must be calculated and interpreted carefully. The alternative of open surgery must be honestly assessed for each individual patient. No single clinician can make these judgments optimally in isolation.

Centres that perform TAVR without a functioning Heart Team structure are not meeting the standard established by international guidelines — and patients are entitled to ask whether the centre they are considering operates within a genuine Heart Team model.

Who Benefits Most from TAVR?

As TAVR technology and evidence have evolved, the patient population it serves has expanded. Originally introduced for patients at prohibitive or high surgical risk, the evidence base now supports TAVR in intermediate-risk and even selected low-risk patients.

Elderly patients — particularly those above 75 — are the core TAVR population. Age-related frailty and comorbidities increase surgical risk substantially, and TAVR’s minimally invasive nature is especially well-suited to this group.

High surgical risk patients—those with severe lung disease, prior cardiac surgery, renal impairment, or STS PROM surgical risk scores above 8%—are prime TAVR candidates regardless of age.

Patients who have been told they are “inoperable”—this is an important category. As TAVR technology has matured and operator experience has grown, anatomical configurations that were once considered unsuitable for TAVR are increasingly treatable. A second opinion from an experienced TAVI expert in India may reveal options that a previous evaluation missed.

Intermediate-risk patients — based on PARTNER 2 and SURTAVI trial data, TAVR produces outcomes comparable to surgery in intermediate-risk patients, expanding its appropriate use further into the mainstream valvular population.

The Evidence Behind TAVR

TAVR is one of the most rigorously evaluated interventions in modern cardiology. The PARTNER trial series, the SURTAVI trial, the EVOLUT trials, and a large body of real-world registry data have collectively established a strong evidence base for TAVR across risk strata. Five-year and early ten-year durability data confirm that TAVR valve function is maintained well in the medium term.

This evidence base is what has driven the transformation of TAVR from a last-resort procedure for the truly inoperable to a mainstream treatment option discussed for the majority of patients presenting with severe symptomatic aortic stenosis.

The First Step for Indian Patients and Families

For anyone navigating an aortic stenosis diagnosis—whether for themselves or for an older family member—the most important action is to seek evaluation at a center with a genuine TAVR program. Not every cardiologist is trained in structural heart disease. Not every hospital advertising cardiac services has the infrastructure, team, and case volume to deliver TAVR safely.

Dr. Raghu is a recognized TAVR/TAVI specialist in India, practicing in Hyderabad, with extensive structural heart disease experience and a Heart Team program that meets current international standards. Patients from across India and internationally consult his practice for TAVR evaluation, second opinions, and complex structural heart care.

The first step is a comprehensive evaluation — clinical assessment, echocardiography, and cardiac CT — that answers the question of whether TAVR, surgical valve replacement, or another approach is the right path for this specific patient. That evaluation, done well, changes outcomes.

Contact Dr. Raghu’s team in Hyderabad through to schedule a TAVR evaluation or structural heart consultation.

 


9-1-1.jpg

February 2, 2024 AbhijitHearty Life

TAVR

Transcatheter Aortic Valve Replacement (TAVR) has emerged as a revolutionary procedure in the field of cardiology, providing a less invasive alternative to traditional open-heart surgery for patients suffering from severe aortic valve stenosis. Recent advancements have expanded the applications of TAVR to include patients with concomitant coronary artery disease (CAD), presenting a groundbreaking approach to addressing multiple cardiac issues simultaneously.

In this article, we will take a closer look at the benefits and key considerations for TAVR with concomitant CAD.

Understanding TAVR

Transcatheter Aortic Valve Replacement (TAVR), also known as Transcatheter Aortic Valve Implantation (TAVI), is a medical procedure used to treat aortic valve stenosis. Aortic valve stenosis is a condition in which the aortic valve in the heart becomes narrowed, restricting the flow of blood from the heart to the rest of the body.

Traditionally, aortic valve replacement has been performed through open-heart surgery, involving the removal of the diseased valve and its replacement with a prosthetic valve. However, TAVR offers a less invasive alternative for certain patients, especially those who are considered high-risk or ineligible for open-heart surgery due to age or other health issues.

Concomitant Coronary Artery Disease and TAVR

Concomitant Coronary Artery Disease (CAD) refers to the presence of atherosclerosis or plaque buildup in the coronary arteries alongside aortic stenosis. In the past, patients requiring both aortic valve replacement and coronary artery intervention would often undergo separate procedures. However, recent studies have explored the feasibility and efficacy of combining TAVR with percutaneous coronary intervention (PCI) in a single hybrid procedure.

Benefits of combining TAVR with concomitant CAD treatment include:

Reduced Procedural Burden

Combining TAVR with PCI in a single procedure reduces the overall procedural burden on the patient. This minimizes the need for multiple hospitalizations, lowers the risk of complications, and accelerates the overall recovery process.

Multifaceted Approach

TAVR with concomitant CAD allows physicians to address both aortic valve stenosis and coronary artery blockages in one session. This multifaceted approach enhances patient outcomes by comprehensively managing multiple cardiac issues simultaneously.

Minimized Anesthesia Exposure

Performing a single hybrid procedure limits the duration of anesthesia exposure for the patient, which can be particularly beneficial for elderly individuals or those with comorbidities who may be more sensitive to prolonged anesthesia.

Streamlined Postoperative Care

Streamlining interventions into a single procedure simplifies postoperative care, as patients only need to recover from one surgery. This may contribute to shorter hospital stays and a more efficient rehabilitation process.

Challenges and Considerations for TAVR With Concomitant CAD

While TAVR with concomitant CAD presents promising advantages, several challenges and considerations need to be addressed:

Patient Selection

Careful patient selection is crucial to ensure that individuals are suitable candidates for combined TAVR and PCI. Factors such as anatomical considerations, the complexity of coronary artery disease, and overall patient health must be thoroughly evaluated.

Technical Challenges

Performing both TAVR and PCI in a single procedure poses technical challenges that demand a high level of expertise from the interventional cardiology team. This includes precise coordination, imaging guidance, and a deep understanding of the complexities associated with both procedures.

Optimal Timing

Determining the optimal timing for TAVR with concomitant CAD remains a subject of ongoing research. Balancing the urgency of aortic valve replacement with the planning required for coronary intervention is crucial for achieving optimal outcomes.

Final Thoughts

The integration of TAVR with concomitant CAD marks a significant stride forward in the realm of cardiovascular interventions. This approach offers a promising solution for patients with multiple cardiac conditions, streamlining the treatment process and potentially improving overall outcomes. As ongoing research continues to refine patient selection criteria and procedural techniques, the future of TAVR with concomitant CAD holds great promise in revolutionizing the landscape of cardiovascular medicine.

Dr. C Raghu is regarded as the best cardiologist in Hyderabad. He specializes in interventional cardiology and has treated countless patients with severe heart ailments. If you or anyone you know is looking for TAVR surgery in Hyderabad, reach out to Dr. Raghu today. 

Book Online Consultaion





    TAVR With Concomitant Coronary Artery Disease (CAD): A Detailed Guide

    DOWNLOAD PDF

    Subscribe the Hearty Life Blogs

      dr. raghu

      DR. RAGHU | Best Cardiologist in Hyderabad

      MD, DM, FESC, FACC, FSCAI

      Cardiology Coronary, Vascular and

      Structural Interventions



      Conditions & Diseases

      Coronary angioplasty

      Angioplasty

      Coronary angioplasty

      Aortic Stenosis

      Coronary angioplasty

      Atrial Fibrillation

      Coronary angioplasty

      Atrial Septal Defect


      View More Services


      Open-Heart-Surgery-vs.-TAVR-1.jpg

      June 13, 2023 AbhijitHearty Life

      Open heart surgery and TAVR are two distinct approaches to treating aortic valve stenosis. Open heart surgery remains the gold standard for its durability and versatility in addressing complex cases. On the other hand, TAVR presents a less invasive alternative, particularly beneficial for high-risk patients and those who cannot undergo traditional surgery.



      Dr raghu logo




      Dr raghu logo






      Call us now if you are in a medical emergency need, we will reply swiftly and provide you with a medical aid.


      For Appointment with Dr Raghu: +91 80085 36699
      Dr Raghu’s Patient Coordinator: +91 72860 10203
      Dr Raghu’s Office Experience: +91 90001 65962
      Dr Raghu’s Social Media Communication Channel: +91 97046 51708

      Dr. Raghu | Heart Specialist in Hyderabad
      Yashoda Hospitals, Raj Bhavan Road, Somajiguda, 1st floor, Room No. 115, Hyderabad -500082, Telangana

      Best Cardiologists in Hyderabad


      © 2024, Dr. Raghu. All rights reserved. Design & Developed by AMSDigital.in

      [gtranslate]
      +91-9542475650